132 related articles for article (PubMed ID: 38442886)
21. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
[TBL] [Abstract][Full Text] [Related]
22. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
[TBL] [Abstract][Full Text] [Related]
23. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.
Kong JC; Guerra GR; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2017 Mar; 60(3):335-345. PubMed ID: 28177997
[TBL] [Abstract][Full Text] [Related]
24. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
[TBL] [Abstract][Full Text] [Related]
25. Watch and wait approach to rectal cancer: A review.
Pozo ME; Fang SH
World J Gastrointest Surg; 2015 Nov; 7(11):306-12. PubMed ID: 26649153
[TBL] [Abstract][Full Text] [Related]
26. Watch and wait approach in rectal cancer: Current controversies and future directions.
López-Campos F; Martín-Martín M; Fornell-Pérez R; García-Pérez JC; Die-Trill J; Fuentes-Mateos R; López-Durán S; Domínguez-Rullán J; Ferreiro R; Riquelme-Oliveira A; Hervás-Morón A; Couñago F
World J Gastroenterol; 2020 Aug; 26(29):4218-4239. PubMed ID: 32848330
[TBL] [Abstract][Full Text] [Related]
27. Salvage surgery for local regrowths in Watch & Wait - Are we harming our patients by deferring the surgery?
Nasir I; Fernandez L; Vieira P; Parés O; Santiago I; Castillo-Martin M; Domingos H; Cunha JF; Carvalho C; Heald RJ; Beets GL; Parvaiz A; Figueiredo N
Eur J Surg Oncol; 2019 Sep; 45(9):1559-1566. PubMed ID: 31006589
[TBL] [Abstract][Full Text] [Related]
28. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
[TBL] [Abstract][Full Text] [Related]
31. Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study.
Barina A; De Paoli A; Delrio P; Guerrieri M; Muratore A; Bianco F; Vespa D; Asteria C; Morpurgo E; Restivo A; Coco C; Pace U; Belluco C; Aschele C; Lonardi S; Valentini V; Mantello G; Maretto I; Del Bianco P; Perin A; Pucciarelli S
Tech Coloproctol; 2017 Aug; 21(8):633-640. PubMed ID: 28755256
[TBL] [Abstract][Full Text] [Related]
32. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.
Habr-Gama A; Gama-Rodrigues J; São Julião GP; Proscurshim I; Sabbagh C; Lynn PB; Perez RO
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):822-8. PubMed ID: 24495589
[TBL] [Abstract][Full Text] [Related]
33. Synchronous Locally Advanced Rectal Cancer with Clinical Complete Remission and Important Downstaging after Neoadjuvant Radiochemotherapy - Personalised Therapeutic Approach.
Georgescu DE; Georgescu MT; Bobircă FT; Georgescu TF; Doran H; Pătraşcu T
Chirurgia (Bucur); 2017; 112(6):726-733. PubMed ID: 29288615
[TBL] [Abstract][Full Text] [Related]
34. A practical review of watch-and-wait approach in rectal cancer.
Byun HK; Koom WS
Radiat Oncol J; 2023 Mar; 41(1):4-11. PubMed ID: 37013413
[TBL] [Abstract][Full Text] [Related]
35. “Watch and wait“ strategy in the treatment of patients with rectal carcinoma.
Ihnát P
Rozhl Chir; 2021; 100(11):517-521. PubMed ID: 35021844
[TBL] [Abstract][Full Text] [Related]
36. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
[TBL] [Abstract][Full Text] [Related]
37. Evolving role of neoadjuvant therapy in rectal cancer.
Schrag D
Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of real world 'watch and wait' data for rectal cancer after neoadjuvant chemoradiotherapy.
Simpson G; Hopley P; Wilson J; Day N; Haworth A; Montazeri A; Smith D; Titu L; Anderson J; Agbamu D; Walsh C
Colorectal Dis; 2020 Nov; 22(11):1568-1576. PubMed ID: 32686268
[TBL] [Abstract][Full Text] [Related]
39. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
[TBL] [Abstract][Full Text] [Related]
40. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
